“…Cylindromatosis patients carry heterozygous germ-line mutations in the carboxyl-terminal end of the CYLD gene, but the wild-type CYLD allele undergoes loss of heterozygosity, indicating that CYLD appears as a tumor-suppressor gene (Bignell et al, 2000). Cylindromas are usually benign, although occasionally they can malignize (Durani et al, 2001;De Francesco et al, 2005). Additional studies have associated Cyld downregulation with the development of other types of human cancer including tumors of colon, lung and kidney, as well as melanomas and cervical and hepatocellular carcinomas (Strobel et al, 2002;Hashimoto et al, 2004;Hirai et al, 2004;Costello et al, 2005;Hellerbrand et al, 2007;Keats et al, 2007;Zhong et al, 2007;Massoumi et al, 2009).…”